Recent Quotes
My Watchlist
Indicators
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Arqule Inc (NQ: ARQL )

20.00 USD UNCHANGED
Last Price Updated: 5:01 PM EST, Jan 15, 2020 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All news about Arqule Inc

< Previous 1 2 3 4 5 6 7 8 9
...
29 30 Next >
These 2 Stocks Could Be 2020's Best Profit Opportunities
How do we find the top stock of 2020? The best performers in 2019 offer some clues. 
Tags AXSM ARQL CNST
From Motley Fool
Merck Completes Acquisition of ArQule
Merck Completes Acquisition of ArQule 
From Business Wire News Releases
The 10 Best-Performing Micro-Cap Stocks of 2019
In 2019 the S&P 500 Index rose an astounding 29%. Much of that gain is the result of a horrible end to 2018 that saw stocks bottom the day before Christmas. Here were the 10 best-performing micro-cap... 
Tags Pharma/Biotech
From Blogs - TalkMarkets
Dollar Tree Stock Is Down 20%, But Investors Should Reject Mini-Tender Offer
It's a good bet the buyer thinks the stock is going to go up. 
Tags Market News ARQL DLTR
From Motley Fool
These Were the 10 Best Stocks of 2019
Seven biotechs led the way. 
Tags SSI RCEL EVER
From Motley Fool
Moore Kuehn, PLLC Encourages Investors of KEM, ARQL, THOR, and LOGM to Contact the Firm
Moore Kuehn, PLLC, a securities law firm located on Wall Street in downtown New York City, is investigating potential claims concerning whether the following proposed mergers are fair to shareholders: 
From PR Newswire
Why Biotech Stock ArQule Soared 108% in December
This cancer-drug developer received a buyout offer from a big pharmaceutical company. 
Tags MRK Market News ARQL
From Motley Fool
SHAREHOLDER INVESTIGATION: Halper Sadeh LLP Investigates Whether The Sale Of These Companies Is Fair To Shareholders – INST, THOR, TCBI, ARQL
From GlobeNewswire News Releases
THOR, ARQL, TIF, and AMTD SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Reminds Investors of Investigations of Buyouts
From GlobeNewswire News Releases
Here are the best-performing Nasdaq stocks of 2019
AMD, Lam Research and KLA top the list. 
Tags SWKS SBAC MKTX
From MarketWatch
SHAREHOLDER INVESTIGATION: Halper Sadeh LLP Investigates Whether The Sale Of These Companies Is Fair To Shareholders - THOR, ARQL, LOGM
From ACCESSWIRE
A Perspective On Biopharma's Record M&A Run In 2019
This year was a watershed one for biopharma M&A, with several multibillion-dollar deals announced thus far. M&A activity in ... 
Tags SLDB THOR QURE
From Benzinga
These Were the 10 Best Healthcare Stocks of 2019
Helping people stricken with illness can be richly rewarding in more ways than one. 
Tags MRK THC BBIO
From Motley Fool
SHAREHOLDER INVESTIGATION: Halper Sadeh LLP Investigates Whether The Sale Of These Companies Is Fair To Shareholders - CRCM, TCBI, ARQL
From ACCESSWIRE
Why Aptose Biosciences Shares Are Jumping Today
Investors excited about the biotech's prospects are taking the opportunity to buy on the dip following the announcement of a new stock offering. 
Tags MRK APTO Market News
From Motley Fool
Merck Begins Tender Offer to Acquire ArQule
Merck Begins Tender Offer to Acquire ArQule 
From Business Wire News Releases
SHAREHOLDER INVESTIGATION: Halper Sadeh LLP Investigates Whether The Sale Of These Companies Is Fair To Shareholders – ARQL, KEM, CBPX, TECD
From GlobeNewswire News Releases
The Week Ahead In Biotech: Avadel, Epizyme In Focus In A Quiet Week
Biotech stocks were seen consolidating last week after advancing in the previous week. The iShares NASDAQ Biotechnology Index (NASDAQ: ... 
Tags News Benzinga FDA
From Benzinga
Better Buy: Eli Lilly vs. Merck
Which of these two pharmaceutical giants is poised to produce healthier returns? 
Tags MRK NVO LLY
From Motley Fool
SHAREHOLDER ALERT: WeissLaw LLP Investigates ArQule, Inc.
WeissLaw LLP is investigating possible breaches of fiduciary duty and other violations of law by the Board of Directors of ArQule, Inc. ("ArQule" or the "Company") (NASDAQ: ARQL) in connection with the... 
From PR Newswire
Notable Thursday Option Activity: FOSL, ARQL, ATNX
Looking at options trading activity among components of the Russell 3000 index, there is noteworthy activity today in Fossil Group Inc (FOSL), where a total volume of 7,870 contracts has been traded... 
Tags Stocks
From Market News Video
There’s more upside for biotech even after 24% gains in two months
Seven biotech stocks to consider buying. 
Tags SNY CH:NOVN FR:SAN
From MarketWatch
The Daily Biotech Pulse: European Nod For Amgen, miRagen Overhauls Clinical Pipeline, Tonix Snags Patent Win
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech stocks hitting ... 
Tags ONCS GRTS Trading Ideas
From Benzinga
Hot Options Report For End Of Day - Wednesday, Dec. 11
Top tickers for end of day: DHR, ARQL, AAPL, F, GILD, FANG, PCG. 
Tags Options
From Blogs - TalkMarkets
Why Merck, Sanofi News Helped This Biotech Rocket 31% Over Two Days
Principia Biopharma stock has rocketed 31% this week amid enthusiasm for its technology, BTK inhibition — highlighted by notable moves from pharmaceutical giants Merck and Sanofi. 
From Investor's Business Daily
Most Active Equity Options For Midday - Wednesday, Dec. 11
Top tickers for midday: AAPL, DHR, TSLA, BAC, BA, MU, FCX, NFLX, AMD, MSFT, BABA, F, PCG, HD, DIS, FANG, ROKU, GME, PTON, ARQL. 
Tags Options
From Blogs - TalkMarkets
The Daily Biotech Pulse: Correvio Faces FDA Panel Rejection, Iterum's Antibiotic Trial Narrowly Misses Primary Endpoint
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech stocks hitting ... 
Tags IDRA PRNB BHC
From Benzinga
Why Biotech ETFs Are Surging To New Highs
We have seen very strong M&A activity in the biotech space of late and the trend is expected to continue as big pharmaceutical companies are trying to gain an edge in the increasingly competitive... 
Tags Pharma/Biotech Stocks / Equities ETFs
From Blogs - TalkMarkets
Hot Options Report For End Of Day - Tuesday, Dec. 10
Top tickers for end of day: DHR, AAPL, ARQL, F, LPI, T. 
Tags Options
From Blogs - TalkMarkets
Investors shift attention to next generation of CAR-T, new sickle cell treatments at major hematology meeting
A handful of sickle cell disease treatments and CAR-T therapies that treat cancer have been approved by the Food and Drug Administration in recent years, but a new crop of investigational therapies... 
Tags GILD MRK ARQL
From MarketWatch
< Previous 1 2 3 4 5 6 7 8 9
...
29 30 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.